|
|
Volumn 34, Issue 7, 2002, Pages 2929-2930
|
|
Maintenance treatment of primary plasma cell leukemia with interferon alpha
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BETA 2 MICROGLOBULIN;
DEXAMETHASONE;
DOXORUBICIN;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN M;
MELPHALAN;
PARAPROTEIN;
RECOMBINANT ALPHA2B INTERFERON;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
ADULT;
AGED;
ANEMIA;
BONE MARROW BIOPSY;
BONE RADIOGRAPHY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CASE REPORT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEGENERATIVE DISEASE;
FEMALE;
HEMOGLOBIN DETERMINATION;
HOSPITAL ADMISSION;
HUMAN;
IMMUNOELECTROPHORESIS;
IMMUNOGLOBULIN BLOOD LEVEL;
LEUKOCYTE COUNT;
LOW BACK PAIN;
MALE;
PAIN;
PLASMA CELL;
PLASMA CELL LEUKEMIA;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN URINE LEVEL;
PROTEINURIA;
RECURRENT DISEASE;
REMISSION;
SHOULDER PAIN;
SPINE DISEASE;
SYMPTOM;
THIGH;
THROMBOCYTE COUNT;
URINALYSIS;
VERTEBRA FRACTURE;
ARTICLE;
FATALITY;
MIDDLE AGED;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
FATAL OUTCOME;
FEMALE;
HUMANS;
INTERFERON-ALPHA;
LEUKEMIA, PLASMACYTIC;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
|
EID: 0036843502
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03492-9 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (17)
|
